Prof Keith Muir
University of Glasgow, Institute for Cardiovascular and Medical Sciences
Papers relevant to this talk:
Muir, K.W. , Sinden, J., Miljan, E. and Dunn, L. (2011) Intracranial delivery of stem cells. Translational Stroke Research, 2(3), pp. 266-271.
Kalladka, D. and Muir, K.W. (2011) Stem cell therapy in stroke: designing clinical trials. Neurochemistry International, 59(3), pp. 367-370.
Sinden, J.D. and Muir, K.W. (2012) Stem cells in stroke treatment: the promise and the challenges. International Journal of Stroke, 7(5), pp. 426-434.
Savitz, S. I. et al. (2014) Stem cells as an emerging paradigm in Stroke 3: enhancing the development of clinical trials. Stroke, 45(2), pp. 634-639.
Kalladka, D. et al. (2016) Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet, 388(10046), pp. 787-796.
Muir, K. W. (2017) Clinical trial design for stem cell therapies in stroke: What have we learned? Neurochemistry International, 106, pp. 108-113.
Detante, O., Muir, K. and Jolkkonen, J. (2018) Cell therapy in stroke—cautious steps towards a clinical treatment. Translational Stroke Research, 9(4), pp. 321-332.
More about Keith' research & Papers: https://www.gla.ac.uk/researchinstitutes/neurosciencepsychology/staff/keithmuir/#/publications,articles
Related blogpost: John Sinden on CTX-2 cells talk at the TCES 2016